Ströbel P - Search Results

1

Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.

Leite MI, Ströbel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A. Leite MI, et al. Among authors: strobel p. Ann Neurol. 2005 Mar;57(3):444-8. doi: 10.1002/ana.20386. Ann Neurol. 2005. PMID: 15732104

2

Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas.

Ströbel P, Helmreich M, Kalbacher H, Müller-Hermelink HK, Marx A. Ströbel P, et al. Dev Immunol. 2001;8(3-4):279-90. doi: 10.1155/2001/49127. Dev Immunol. 2001. PMID: 11785677 Free PMC article.

3

Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.

Ströbel P, Helmreich M, Menioudakis G, Lewin SR, Rüdiger T, Bauer A, Hoffacker V, Gold R, Nix W, Schalke B, Elert O, Semik M, Müller-Hermelink HK, Marx A. Ströbel P, et al. Blood. 2002 Jul 1;100(1):159-66. doi: 10.1182/blood.v100.1.159. Blood. 2002. PMID: 12070022 Free article.

4

Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas.

Inoue M, Starostik P, Zettl A, Ströbel P, Schwarz S, Scaravilli F, Henry K, Willcox N, Müller-Hermelink HK, Marx A. Inoue M, et al. Among authors: strobel p. Cancer Res. 2003 Jul 1;63(13):3708-15. Cancer Res. 2003. PMID: 12839963

5

Pathomechanisms of paraneoplastic myasthenia gravis.

Ströbel P, Preisshofen T, Helmreich M, Müller-Hermelink HK, Marx A. Ströbel P, et al. Clin Dev Immunol. 2003 Mar;10(1):7-12. doi: 10.1080/10446670310001598528. Clin Dev Immunol. 2003. PMID: 14575152 Free PMC article.

6

The role of thymomas in the development of myasthenia gravis.

Marx A, Müller-Hermelink HK, Ströbel P. Marx A, et al. Among authors: strobel p. Ann N Y Acad Sci. 2003 Sep;998:223-36. doi: 10.1196/annals.1254.025. Ann N Y Acad Sci. 2003. PMID: 14592880 Review.

7

Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis.

Ströbel P, Bauer A, Puppe B, Kraushaar T, Krein A, Toyka K, Gold R, Semik M, Kiefer R, Nix W, Schalke B, Müller-Hermelink HK, Marx A. Ströbel P, et al. J Clin Oncol. 2004 Apr 15;22(8):1501-9. doi: 10.1200/JCO.2004.10.113. J Clin Oncol. 2004. PMID: 15084623

8

Selective loss of regulatory T cells in thymomas.

Ströbel P, Rosenwald A, Beyersdorf N, Kerkau T, Elert O, Murumägi A, Sillanpää N, Peterson P, Hummel V, Rieckmann P, Burek C, Schalke B, Nix W, Kiefer R, Müller-Hermelink HK, Marx A. Ströbel P, et al. Ann Neurol. 2004 Dec;56(6):901-4. doi: 10.1002/ana.20340. Ann Neurol. 2004. PMID: 15562414

9

Thymoma and thymic carcinoma: an update of the WHO Classification 2004.

Ströbel P, Marx A, Zettl A, Müller-Hermelink HK. Ströbel P, et al. Surg Today. 2005;35(10):805-11. doi: 10.1007/s00595-005-3047-y. Surg Today. 2005. PMID: 16175459 Review.

10

A CTLA4high genotype is associated with myasthenia gravis in thymoma patients.

Chuang WY, Ströbel P, Gold R, Nix W, Schalke B, Kiefer R, Opitz A, Klinker E, Müller-Hermelink HK, Marx A. Chuang WY, et al. Among authors: strobel p. Ann Neurol. 2005 Oct;58(4):644-8. doi: 10.1002/ana.20577. Ann Neurol. 2005. PMID: 16178018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

436 results

Search Page